Dr. Luc Biedermann attended medical school in Basel, Switzerland. After board certification in internal medicine at the University Hospital Zurich, he specialized in gastroenterology (2nd board certification). He currently works as a senior physician at the division of Gastroenterology & Hepatology of the University Hospital Zurich (USZ) chaired by Prof. Michael Fried.
Among his main clinical and research interests are inflammatory bowel disease (IBD) and also celiac disease as well recurrent clostridium difficile colitis. Under the lead of Prof. Gerhard Rogler he works in his main clinical focus in the inflammatory bowel disease clinic of the University Hospital Zurich, a tertiary referral center for ambulatory and in-house care for IBD patients in Switzerland.
Dr. Biedermann is especially interested in aspects of intestinal microbiota, epidemiology and alternative treatment options in IBD. The possibility of providing patients new treatment options within clinical trials is an important component in the care of IBD patients in Zurich. The USZ IBD-clinic participated in a multitude of phase II and III studies, including smaller investigator initiated studies, either multi centre within Switzerland or single center. The topic of his talk will be centered around the results of a small pilot study on the effect of an anthocyanin-rich bilberry preparation in patients with ulcerative colitis.